摘要
为进一步从分子水平研究中药治疗骨质疏松症的机制,将传统中医药与现代医学相结合,通过查阅相关文献,将对中药调节TGF-β表达治疗骨质疏松症的研究进行综述,为骨质疏松症的发病机制及靶向治疗提供参考,为中药治疗骨质疏松症提供科学依据及治疗思路,推动中医药事业的发展。
In order to further study the mechanism of traditional Chinese medicine in the treatment of osteoporosis at molecular level,to combine traditional Chinese medicine and modern medicine,this paper reviews the regulation of TGF-beta expression by traditional Chinese medicine(TCM)based on literature screening.This may provide the reference for the pathogenesis of osteoporosis and targeted therapy,provide scientific basis for Chinese medicine in the treatment of osteoporosis,and promote the development of Chinese medicine.
作者
王雨榕
邓强
李中锋
彭冉东
徐浩军
WANG Yurong;DENG Qiang;LI Zhongfeng;PENG Randong;XU Haojun(Gansu University of Traditional Chinese Medicine,Lanzhou 730030,China;Gansu Provincial Hospital of Traditional Chinese Medicine,Lanzhou 730050,China)
出处
《中国骨质疏松杂志》
CAS
CSCD
北大核心
2020年第9期1391-1394,共4页
Chinese Journal of Osteoporosis
基金
兰州市人才创新创业项目(2017-RC-44)。
关键词
中药
转化生长因子Β
促成骨
骨质疏松症
traditional Chinese medicine
transforming growth factor beta
promoting bone formation
osteoporosis
